Scientific publications

Within the medical and scientific affairs department, our team of medical writers work in close collaboration with all of our operational departments including clinical operations, quality assurance, and biometrics.

They ensure the drafting of all study-related documents and scientific publications including:

▾Clinical and observational study report

▾Articles in compliance with standards of selected publications

▾Posters (with graphics, diagrams, illustrations insertion)

▾Abstracts

Find out how our medical writers, as editors and/or writers, can put clinical results into words and highlight the outcome of your clinical projects by exploring a selection of our articles and posters from the past 5 years.

Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study

Publication
Published in Springer Link – Annals of Hematology – March 2024

Date : 06/03/2024

Authors:

Caroline Dartigeas, Anne Quinquenel, Loïc Ysebaert, Marie-Sarah Dilhuydy, Bruno Anglaret, Borhane Slama, Katell Le Du, Stéphanie Tardy, Emmanuelle Tchernonog, Hubert Orfeuvre, Laurent Voillat, Stéphanie Guidez, Jean-Valère Malfuson, Sandrine Dupuis, Marine Deslandes, Pierre Feugier & Véronique Leblond on behalf of the FIRE Investigators Group

Publication source

Prevention of foot blisters using COMPEED® hydrocolloid plasters: a randomized, open-labelled comparative superiority clinical investigation versus regular plasters.

Publication
Published in Clinical Research and Trials Volume 9: 1-7, 2023 doi: 10.15761/CRT.1000372

Date : 03/08/2023

Authors:

Zakka Bajjani J, Auzou P, James T, Katsogiannou M, Chapalain V, et al. (2023)

Publication source

A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance

Article
Published in Journal of Alzheimer’s Disease

Date : 08/11/2022

Authors:

Blivet G, Relano-Ginesa A, Wachtel M & Touchon J

Publication source

Ponatinib Long-Term Follow-up of Efficacy and Safety in CP-CML Patients in Real World Settings in France: the POST-PACE Study

Article
Published in Leukemia research

Date : 01/05/2021

Authors:

Etienne G, Rea D, Coiteux V, Guerci-Bresler A, Huguet F, Legros L, Rousselot P & Nicolini FE

Publication source

Scientific and methodological consistency throughout a clinical study: How to succeed?

Poster
Presented at PHUSE congress 2020

Date : 02/11/2020

Authors:

S. Wiederkehr, C. Rigault, V. Chapalain, R. Gauchoux – ICTA PM, Fontaine Lès Dijon

Download PDF

Amélioration de la qualité de vie et de la continence des patients atteints de RCH distale, traités par Mésalazine. Étude QUARTZ

Poster
Presented during the French JFHOD event (Journées Françaises d’Hépato-Oncologie Digestive)

Date : 25/09/2020

Authors:

Paupard T, Gonzalez F, Siprhoudhis L & Peyrin-Biroulet L

Publication source

Exploitation des Données de Vie Réelle Issues d’un Registre en Oncologie : Comment Identifier les Lignes de Chimiothérapie d’une Cohorte de Patientes Atteintes d’un Cancer Ovarien

Poster
Presented during the 12th “Colloque Données de santé en vie réelle” (event on health data issued from the real world) organised by AFCROs

Date : 18/09/2020

Authors:

J.Skrzypski, E.Yon, V.Chapalain, S.Wiederkehr, R.Gauchoux – ICTA PM, Fontaine Lès Dijon

Download PDF

Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies: A Real-World Experience in France.

Article
Published in Digestive Diseases and Sciences

Date : 18/04/2020

Authors:

Ouzan D, Larrey D, Guyader D, Remy AJ, Riachi G, Heluwaert F, Truchi R, Combis JM, Bailly F, Rosa I, Hézode C, Glorian-Petraud D, Libert O, Ramroth H, Asselah T, Thiefin G, Roulot D, Roche B, Leroy V, Dumortier J, Thabut D & Pol S; HELIOS study group.

Publication source

Improvement of Quality of life and continence in patients with distal ulcerative colitis treated by mesalazine. The QUARTZ study

Poster
Presented at ECCO (European Crohn’s an Colitis Organisation)

Date : 12/02/2020

Authors:

Paupard T, Gonzalez F, Siprhoudhis L & Peyrin-Biroulet L

Publication source

Letermovir for Secondary Prophylaxis of Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Cell Transplantation: Results from the French Compassionate Program

Article
Published in Biology of Blood and Marrow Transplantation

Date : 05/02/2020

Authors:

Robin C, Thiebaut A, Alain S, Sicre de Fontbrune F, Berceanu A, D’Aveni M, Ceballos P, Redjoul R, Nguyen-Quoc S, Bénard N, Pahlavan-Grumel G & Cordonnier C

Publication source

Ponatinib Long-Term Follow-up of Efficacy and Safety in CP-CML Patients in Real World Settings in France: The Post-PACE Study

Poster
Presented during the “ESH-iCML (Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy)” congress

Date : 12/09/2019

Authors:

Nicolini FE, Rea D, Coiteux V, Guerci-Bresler A, Huguet F, Karsenti JM, Legros L, Rousselot P & Etienne G

Phase 2 study results of Murlentamab, a monoclonal antibody targeting the anti-mullerian hormone receptor II (AMHRII), acting through tumor associated macrophage (TAM) engagement in advanced/metastatic colorectal cancer

Poster
Presented at ESMO WCGIC (World Congress on Gastrointestinal Cancer) – 2019

Date : 03/07/2019

Authors:

Van Cutsem E, Melichar B, Van Den Eynde M, Prausova J, Geboes K, Dekervel J, Vitaskova D, De Cuyper A, Linke Z, Van Acker N, Frenois FX, Noël G, Prost JF, Barret JM, Jean B & Tabah-Fisch I

Publication source

Étude observationnelle, prospective décrivant les caractéristiques et la prise en charge de femmes atteintes d’une ostéoporose post-ménopausique traitées par Prolia® et son utilisation en pratique clinique courante en France (étude PILOTE)

Article
Published in the magazine “Revue d’épidémiologie et de santé publique”

Date : 01/06/2019

Authors:

Schott AM, Briot K, Sanchez P, Bendavid S, Bosquet L, Perot S, Etringer A, Chauny JV, Samama P & Désaméricq G

Publication source

First-in-human first-in-class phase I trial of Murlentamab, a an Anti-Müllerian-Hormone-Receptor II (AMHRII) monoclonal antibody acting through Tumor Associated Macrophage (TAM) engagement, as single agent and in combination with Carboplatin (C) and Paclitaxel (P) in AMHRII-expressing advanced/metastatic gynecological cancer patients (pts)

Poster
Presented at ASCO (American Society of Clinical Oncology) 2019

Authors:

Leary A, Awada A, Delord JP, Floquet A, Ray-Coquard I, Abdeddaim C, Fabbro M, Kalbacher E, Vergote I, Banerjee S, Frenois FX, Noel G, Lantz O, Cassard L, Coste A, Villard M, Lemée F, Tabah-Fisch I & Le Tourneau C

Publication source

No effect of alcohol consumption or dependence on treatment outcome in chronic hepatitis C patients treated with Elbasvir/Grazoprevir in real-world setting

Poster
Presented at EASL (European Association for the Study of the Liver)

Date : 10/04/2019

Authors:

Bronowicki JP, Miailhes P, Hanslik B, Abergel A, Larrey D, Pospait D, Truchi R, Ouzan D, Jouannaud V, Perrot S, Skrzypski J, Liautard C, Estrabaud E, Spampinato A, Guidoum A & Sogni P

Publication source

Letermovir for prophylaxis of Cytomegalovirus (CMV) infection or disease in allogeneic HCT recipients: experience of secondary prophylaxis in the French Compassionate program

Poster
Presented at EBMT (European Society of Blood and Marrow Transplantation) 2019

Date : 24/03/2019

Authors:

Robin C, Thiebaut A, Alain S, Sicre de Fontbrune F, Berceanu A, D’Aveni M, Ceballos P, Redjoul R, Nguyen-Quoc S, Bénard N, Pahlavan-Grumel G & Cordonnier C

Premiers résultats de l’étude multicentrique prospective observationnelle avec l’association elbasvir/grazoprévir dans le traitement de l’hépatite chronique C en France : observatoire ZEPHYR

Poster
Presented at JFHOD (Journées Francophones d’Hépato-gastroentérologie et d’Oncologie Digestive)

Date : 21/03/2019

Authors:

Bronowicki JP, Miailhes P, Hanslik B, Abergel A, Larrey D, Pospait D, Truchi R, Ouzan D, Riachi G, Skrzypski J, Guidoum A, Spampinato A & Sogni P

Filgrastim prophylaxis in elderly cancer patients in the real-life setting: a French multicenter observational study, the TULIP study

Article
Published in Support Care Cancer

Date : 14/03/2019

Authors:

Laribi K, Badinand D, Janoray P, Benabed K, Mouysset JL, Fabre E, Monchecourt F & Diab R

Publication source

Gaucher Disease: Baseline Preliminary Data of the French Eliglustat Patient Reported Outcome Study (ELIPRO)

Poster
Presented during the WORLD Symposium

Date : 04/02/2019

Authors:

Camou F, Gaches F, Cador-Rousseau B, Coutinho A, Belmatoug N & Berger MG

Publication source

Gaucher Disease: Baseline Preliminary Data of the French Eliglustat Patient Reported Outcome Study (ELIPRO)

Poster
Presented at WORLD Symposium

Date : 04/02/2019

Authors:

Camou F, Gaches F, Cador-Rousseau B, Coutinho A, Belmatoug N & Berger MG

Publication source

Micafungin prophylaxis in routine medical practice in adult and pediatric patients with hematological malignancy: a prospective, observational study in France.

Article
Published in Diagnostic Microbiology and Infectious Disease

Date : 26/01/2019

Authors:

El Cheikh J, Ceballos P, Dalle JH, Ducastelle-Leprêtre S, Dulon E & Herbrecht R

Publication source

Technique d’inhalation des sujets asthmatiques utilisant Duoresp Spiromax en condition de vie réelle.

Poster
Presented at CPLF (Congrès de Pneumologie de Langue Française)

Date : 25/01/2019

Authors:

Roch N, Aguilaniu B, Similowski T, Monchecourt F & Deveza P

Publication source

Results and validation of an index to measure health state of patients with depression in automated healthcare databases.

Article
Published in Journal of Market Access & Health Policy

Date : 22/01/2019

Authors:

Lamy FX, Falissard B, François C, Lançon C, Llorca PM, Tanasescu A, Touya M, Verpillat P, Wade AG & Saragoussi D.

Publication source

The challenge of unexplained splenomegalies: preliminary data of the French prospective multi-center SplenoMegalyStudy (SMS)

Poster
Presented at ASH (American Society of Hematology) OUTCOMES RESEARCH-NON-MALIGNANT HEMATOLOGY: POSTER III| NOVEMBER 29, 2018

Date : 29/11/2018

Authors:

Denis G, Sanhes L, Ziza JM, Bauduer F, Berger MG, Costello RT, Mehdi K, Michaud M, Urbanski G & Rose C

Publication source

Etude multicentrique prospective observationnelle de l’association elbasvir/grazoprévir dans le traitement de l’hépatite chronique C en France : observatoire zephyr

Poster
Presented during the “AFEF – Association Française pour l’Étude du Foie” event – Résumé n°P020

Date : 01/10/2018

Authors:

Bronowicki JP, Miailhes P, Hanslik B, Abergel A, Larrey D, Pospait D, Truchi R, Ouzan D, Vernier-Faudot E, Skrzypski J, Guidoum A, Spampinato A & Sogni P

Publication source

Tacrolimus Granules for Oral Suspension as Post-Transplant Immunosuppression in Routine Medical Practice in France: The OPTIMOD Study

Article
Published in Annals of Transplantation

Date : 10/08/2018

Authors:

Garaix F, Stern M, Lamy FX, Dubel L & Kamar N.

Publication source

Systemic Antifungal Prophylaxis in Patients Hospitalized in Hematology Units in France: The AFHEM Cross-Sectional Observational Study.

Article
Published in Infectious Diseases and Therapy

Date : 09/06/2018

Authors:

Gangneux JP, El Cheikh J, Herbrecht R, Yakoub-Agha I, Quiniou JB, Caillot D & Michallet M

Publication source

A First-In-Human study of monoclonal antibody GM102 in patients in patients with Anti Anti -Müllerian -Hormone -Receptor II (AMHRII) positive gynecological cancers

Poster
Presented at ASCO (American Society of Clinical Oncology)

Date : 01/06/2018

Authors:

Leary A, Aftimos PG, Delord JP, Le Tourneau C, Ray-Coquard IL, Jungels C, Varga A, Ricci F, Gomez-Roca CA, Bataillon G, Van Acker N, Noël G, Lantz O, Cassard L, Coste A, Jean B, Tabah-Fisch IM, Vincent-Salomon A, Prost JF & Awada A

Publication source

Prospective evaluation of the effect of deferasirox on hematologic response in transfusion-dependent patients with low-risk MDS and iron overload.

Article
Published in European Journal of Haematology

Date : 02/05/2018

Authors:

Rose C, Lenoir C, Gyan E, Hacini M, Amé S, Corront B, Beyne-Rauzy O, Adiko D, Loppinet E, Ali-Ammar N, Laribi K, Wattel E, Dreyfus F, Roué CS & Cheze S

Publication source

Apixaban in the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: Rationale and design of the PAROS cross-sectional study

Article
Published in Archives of Cardiovascular Diseases

Date : 01/05/2018

Authors:

Picard F, Ducrocq G, Danchin N, Falissard B, Hanon O, Mahe I, Touzé E & Steg PG

Publication source

An Auto-Adjustable Night Garment to Control Early Rebound Effect of Edema Volume After Intensive Phase of Decongestive Lymphedema Therapy

Article
Publié dans la revue “Lymphatic Research and Biology”

Date : 01/12/2017

Authors:

Mestre S, Gaillard G, Benhamou M, Soulier-Sotto V, Nou M, Pasqualini M, Amor CB & Quere I.

Publication source

Creating an index to measure health state of depressed patients in automated healthcare databases: the methodology

Article
Published in Journal of Market Access & Health Policy 2017

Date : 13/09/2017

Authors:

François C, Tanasescu A, Lamy FX, Despiegel N, Falissard B, Chalem Y, Lançon C, Llorca PM, Saragoussi D, Verpillat P, Wade AG & Zighed DA

Publication source

Poor sleep is highly associated with house dust mite allergic rhinitis in adults and children.

Article
Published in Allergy, Asthma & Clinical Immunology

Date : 16/08/2017

Authors:

Leger D, Bonnefoy B, Pigearias B, de La Giclais B & Chartier A

Publication source

Interest of an auto-adjustable nighttime compression sleeve (MOBIDERM® Autofit) in maintenance phase of upper limb lymphedema: the MARILYN pilot RCT.

Article
Published in Supportive Care in Cancer

Date : 09/03/2017

Authors:

Mestre S, Calais C, Gaillard G, Nou M, Pasqualini M, Ben Amor C & Quere I.

Publication source

RGPD compliant
21 CFR Part 11 compliance
crédit d'impôt recherche
bureau veritas certification icta
bureau veritas certification icta